CAS RN: 106-55-8

2,5-Dimethylpiperazine

Product Availability

Choose a grade to view its available package options.

1 package records0 with current stock1 grade group
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20250714 100mg / 250mg / 1g Out of stock 5-7 business days Inquiry
  • Product code: SSC-007650
GET A QUOTE
Verified Factory Data

Supply Overview & Packaging Options

Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.

  • Pack sizes on record: 0.1g, 0.25g, 1g, 5g
  • Available purity: ≥95%
  • Inventory rows with stock: 4
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Available Pack Sizes & Stock

Specific stock quantities are shown below. Price is not displayed online and is confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 106-55-8
Pack Size Recorded Purity Available Qty Ship From Inquiry
0.1g ≥95% 5 In Stock Beijing Inquiry
0.25g ≥95% 2 In Stock Shenzhen Inquiry
1g ≥95% 1 In Stock Shanghai Inquiry
5g ≥95% 1 In Stock Beijing Inquiry

106-55-8 / 2,5-dimethylpiperazine

2,5-DIMETHYLPIPERAZINE | Piperazine, 2,5-dimethyl- | EINECS 203-409-4

Standard CAS: 106-55-8 Multi CAS: Yes

Basic Information

CAS
106-55-8
Multi CAS
Yes
Molecular Formula
C6H14N2
Molecular Weight
114.190000
Exact Mass
114.115698
SMILES
CC1CNC(CN1)C
InChI
InChI=1S/C6H14N2/c1-5-3-8-6(2)4-7-5/h5-8H,3-4H2,1-2H3
InChIKey
NSMWYRLQHIXVAP-UHFFFAOYSA-N
Synonyms
2,5-DIMETHYLPIPERAZINE Piperazine, 2,5-dimethyl- EINECS 203-409-4 BRN 0079885 UNII-ZIZ1G1N25S

Computed Properties

Structural Parameters

Heavy atom count
8
Fraction Csp3
1
H-bond acceptors
2
H-bond donors
2
Molar refractivity
34.93
TPSA
24.06

LogP / Solubility

WLOGP
-0.04
MLOGP
-0.05
Consensus LogP
-0.03
Log S (ESOL)
-0.52
Class (ESOL)
Very soluble
Log S (Ali)
-0.46
Class (Ali)
Very soluble
Log S (SILICOS-IT)
-0.37
Class (SILICOS-IT)
Very soluble

ADME

GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.45

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
2.5

Safety & Transport

Pictogram(s)
Flammable Corrosive Acute Toxic
Signal
Danger
GHS Hazard Statements
H228 (50%): Flammable solid [Danger Flammable solids] H311 (100%): Toxic in contact with skin [Danger Acute toxicity, dermal] H314 (50%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] H228 (100%): Flammable solid [Danger Flammable solids]
Precautionary Statement Codes
P210, P240, P241, P260, P262, P264, P270, P280, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P321, P361+P364, P363, P370+P378, P405, and P501 P210, P240, P241, P262, P264, P270, P280, P302+P352, P316, P321, P361+P364, P370+P378, P405, and P501

Get In Touch

Contact Us